Abstract:Five cases of Kaposi sarcoma with vinblastine sulfate treatment were compared with 18 cases reported in the literature. Our experience with a low-dosage schedule emphasizes that toxicity is not necessary for a favorable result. Vinblastine seems to be an effective treatment for Kaposi sarcoma and, in selected cases, may supplement radiation therapy or be used alone.
“…Both these modalities affect to some degree the immunological defences of the patient and produce unwanted and unpleasant side-effects, particularly with immunosuppressive drugs which may be even lethal [5]. In the cases described in this report, the local and systemic reactions were mild, to such a degree that the patients could have been treated in the outpatient clinic.…”
4 patients with Kaposi’s sarcoma and 1 patient with basal cell carcinoma and solar keratosis were successfully treated with topical application of an ointment containing killed BCG and cord factor.
“…Both these modalities affect to some degree the immunological defences of the patient and produce unwanted and unpleasant side-effects, particularly with immunosuppressive drugs which may be even lethal [5]. In the cases described in this report, the local and systemic reactions were mild, to such a degree that the patients could have been treated in the outpatient clinic.…”
4 patients with Kaposi’s sarcoma and 1 patient with basal cell carcinoma and solar keratosis were successfully treated with topical application of an ointment containing killed BCG and cord factor.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.